Dec. 6, 1999
Therion Appoints Former
Wyeth-Lederle Vaccines President, Ronald J.
Saldarini, Ph.D., to Board of Directors
Nov. 17, 1999
Therion Appoints Richard
Woodrich as
Senior Vice President, Business
Development
Nov. 9, 1999
Therion Awarded AIDS
Vaccine Manufacturing Contracts from NIH
Oct. 18, 1999
Therion Biologics and
National Cancer Institute Initiate Phase II
Trial of Novel Melanoma Vaccines
June 28, 1999
Therion Completes $10.5
Million Financing to Accelerate Cancer Vaccine
Development
Sept. 16,
1998
Therion Obtains Rights to
Novel Gene from Ludwig Institute for Cancer
Vaccines
Jan. 14, 1998
New Agreement to Find
Cancer Vaccines
July 14, 1997
Therion Biologics Issued
Broad U.S. Patents Covering Fundamental AIDS
Vaccine Technology
July 31, 1997
Francis P. Tally, M.D.,
Appointed to Therion Biologics Board of
Directors
Back to top
